Published in AIDS Res Hum Retroviruses on March 01, 2008
Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996-2008). J Int AIDS Soc (2009) 1.65
Reverse transcriptase inhibitors as potential colorectal microbicides. Antimicrob Agents Chemother (2009) 1.26
Phylodynamics of HIV-1 circulating recombinant forms 12_BF and 38_BF in Argentina and Uruguay. Retrovirology (2010) 1.03
Similar replicative fitness is shared by the subtype B and unique BF recombinant HIV-1 isolates that dominate the epidemic in Argentina. PLoS One (2014) 0.85
The Use of Bioinformatics for Studying HIV Evolutionary and Epidemiological History in South America. AIDS Res Treat (2011) 0.81
Tracing the origin and northward dissemination dynamics of HIV-1 subtype C in Brazil. PLoS One (2013) 0.80
Molecular epidemiology of HIV-1 in Panama: origin of non-B subtypes in samples collected from 2007 to 2013. PLoS One (2014) 0.79
Genetic Consequences of Antiviral Therapy on HIV-1. Comput Math Methods Med (2015) 0.78
The HIV-1 epidemic in Bolivia is dominated by subtype B and CRF12_BF "family" strains. Virol J (2012) 0.75
The challenge of antiretroviral drug resistance in HIV-1-infected children. J Pediatr (Rio J) (2009) 0.75
Identification of two HIV type 1 circulating recombinant forms in Brazil. AIDS Res Hum Retroviruses (2006) 1.27
Full-length genome analysis of human immunodeficiency virus type 1 subtype C in Brazil. AIDS Res Hum Retroviruses (2006) 1.16
HIV type 1 transmission by human bite. AIDS Res Hum Retroviruses (2004) 1.15
Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in São Paulo, Brazil. Infect Genet Evol (2006) 1.08
Faster HIV-1 disease progression among Brazilian individuals recently infected with CXCR4-utilizing strains. PLoS One (2012) 1.05
Low accumulation of L90M in protease from subtype F HIV-1 with resistance to protease inhibitors is caused by the L89M polymorphism. J Infect Dis (2005) 1.01
Less sensitive HIV-1 enzyme immunoassay as an adjuvant method for monitoring patients receiving antiretroviral therapy. AIDS Patient Care STDS (2007) 0.99
Vicriviroc in combination therapy with an optimized regimen for treatment-experienced subjects: 48-week results of the VICTOR-E1 phase 2 trial. J Infect Dis (2010) 0.98
High levels of primary antiretroviral resistance genotypic mutations and B/F recombinants in Santos, Brazil. AIDS Patient Care STDS (2007) 0.96
The use of real-time PCR to detect hepatitis C virus RNA in dried blood spots from Brazilian patients infected chronically. J Virol Methods (2011) 0.94
Genetic diversity and HIV-1 incidence estimation among cocaine users in São Paulo, Brazil. J Acquir Immune Defic Syndr (2002) 0.91
Influence of hepatitis B virus (HBV) genotype on the clinical course of disease in patients coinfected with HBV and hepatitis delta virus. J Infect Dis (2009) 0.90
HIV type 1 antiretroviral resistance mutations in subtypes B, C, and F in the City of São Paulo, Brazil. AIDS Res Hum Retroviruses (2010) 0.90
Characterization of virologic failure after an initially successful 48-week course of antiretroviral therapy in HIV/AIDS outpatients treated in Santos, Brazil. Braz J Infect Dis (2008) 0.89
Analysis of full-length human immunodeficiency virus type 1 genome reveals a variable spectrum of subtypes B and f recombinants in São Paulo, Brazil. AIDS Res Hum Retroviruses (2005) 0.88
Similar efficacy of lopinavir/ritonavir-containing regimens among clades B and F HIV-1-Infected individuals in Brazil. J Acquir Immune Defic Syndr (2008) 0.88
Primary resistance of HIV to antiretrovirals among individuals recently diagnosed at voluntary counselling and testing centres in the metropolitan region of Recife, Pernambuco. Mem Inst Oswaldo Cruz (2012) 0.87
Characterization of the full-length human immunodeficiency virus-1 genome from recently infected subjects in Brazil. AIDS Res Hum Retroviruses (2007) 0.85
The association between primary antiretroviral resistance and HAART virologic failure in a developing set. AIDS Res Hum Retroviruses (2010) 0.84
Duplication of peri-kappaB and NF-kappab sites of the first human immunodeficiency virus type 2 (HIV-2) transmission in Brazil. AIDS Res Hum Retroviruses (2005) 0.83
Phenotypic susceptibility to antiretrovirals among clades C, F, and B/F recombinant antiretroviral-naive HIV type 1 strains. AIDS Res Hum Retroviruses (2013) 0.82
Environmental strains of Cryptococcus neoformans variety grubii in the city of Santos, SP, Brazil. Rev Inst Med Trop Sao Paulo (2005) 0.82
Frequency of polymorphisms of genes coding for HIV-1 co-receptors CCR5 and CCR2 in a Brazilian population. Braz J Infect Dis (2003) 0.82
HIV type 1 diversity from newly diagnosed patients in Santos metropolitan area/Brazil. AIDS Res Hum Retroviruses (2009) 0.81
Short communication: high polymorphism rates in the HR1 and HR2 gp41 and presence of primary resistance-related mutations in HIV type 1 circulating in Brazil: possible impact on enfuvirtide efficacy. AIDS Res Hum Retroviruses (2010) 0.81
Loci polymorphisms of the APOBEC3G gene in HIV type 1-infected Brazilians. AIDS Res Hum Retroviruses (2010) 0.81
Relaxation of adaptive evolution during the HIV-1 infection owing to reduction of CD4+ T cell counts. PLoS One (2012) 0.81
Estimating HIV-1 incidence using the serologic testing algorithm for recent HIV infections at HIV counseling and testing centers in the city of São Paulo, Brazil. Braz J Infect Dis (2009) 0.80
Analysis of the origin and evolutionary history of HIV-1 CRF28_BF and CRF29_BF reveals a decreasing prevalence in the AIDS epidemic of Brazil. PLoS One (2011) 0.80
Environmental analyses of the parasitic profile found in the sandy soil from the Santos municipality beaches, SP, Brazil. Rev Inst Med Trop Sao Paulo (2011) 0.80
Incidence of recent human immunodeficiency virus infection at two voluntary counseling testing centers in Pernambuco, Brazil, from 2006 to 2009. J Clin Microbiol (2012) 0.79
Evidence for Selection of more Adapted Human Immunodeficiency Virus Type 1 Recombinant Strains in a Dually Infected Transfusion Recipient. Virus Genes (2004) 0.79
Short communication: HIV type 1 tropism determination in a novel dried blood spot membrane and the use of a mixture of outer nested polymerase chain reaction primers. AIDS Res Hum Retroviruses (2013) 0.79
Reactivation of ancestral strains of HIV-1 in the gp120 V3 env region in patients failing antiretroviral therapy and subjected to structured treatment interruption. Virology (2006) 0.78
Profiling resistance-related mutations in the protease region of the pol gene: single genome sequencing of HIV in plasma and peripheral blood mononuclear cells. AIDS Res Hum Retroviruses (2008) 0.77
HIV-1 drug resistance genotypic profiles in children with undetectable plasma viremia during antiretroviral therapy. Braz J Infect Dis (2011) 0.77
Comparative effectiveness of dried-plasma hepatitis B virus viral load (VL) testing in three different VL commercial platforms using ViveST for sample collection. J Clin Microbiol (2011) 0.77
Association between IL28B gene polymorphisms and sustained virological response in patients coinfected with HCV and HIV in Brazil. J Antimicrob Chemother (2011) 0.77
The detection of in vivo and in vitro HIV type 1 B/F profiles in Brazil using a real-time PCR assay for five HIV type 1 genomic regions. AIDS Res Hum Retroviruses (2010) 0.77
Detection of lamivudine-resistant variants and mutations related to reduced antigenicity of HBsAg in individuals from the cities of Santos and São Paulo, Brazil. Virol J (2013) 0.76
HIV-1 viral load in blood and semen plasma of Brazilian patients under antiretroviral therapy. J Clin Virol (2004) 0.76
Prevalence of potentially pathogenic free-living amoebae from Acanthamoeba and Naegleria genera in non-hospital, public, internal environments from the city of Santos, Brazil. Braz J Infect Dis (2009) 0.76
Decrease in lipoatrophy in a pilot study using a short-term treatment interruption strategy for 48 weeks in São Paulo, Brazil. AIDS Res Hum Retroviruses (2012) 0.76
Codon pairs of the HIV-1 vif gene correlate with CD4+ T cell count. BMC Infect Dis (2013) 0.76
Correction: Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment. PLoS One (2017) 0.75
In vivo HIV-1 hypermutation and viral loads among antiretroviral-naive Brazilian patients. AIDS Res Hum Retroviruses (2014) 0.75
Prevalence and factors associated with HSV-2 and hepatitis B infections among truck drivers crossing the southern Brazilian border. Sex Transm Infect (2011) 0.75
Antiretroviral drug resistance among patients with human immunodeficiency virus who act as sources or potential sources in occupational accidents involving healthcare workers. Infect Control Hosp Epidemiol (2005) 0.75
Homogenous HIV-1 subtype B quasispecies in Brazilian men and women recently infected via heterosexual transmission. Virus Genes (2014) 0.75
Should tenofovir ever be used in association with didanosine? Braz J Infect Dis (2006) 0.75
Long-term HIV-1 suppression in the Brazilian public health system. AIDS Patient Care STDS (2009) 0.75
Saquinavir plus lopinavir/ritonavir versus amprenavir plus lopinavir/ritonavir for treating highly resistant patients in Brazil. J Acquir Immune Defic Syndr (2008) 0.75